SHORE-C Logo
HOME RESEARCH PUBLICATIONS WORKSHOPS FILMS APPS TALKS NEWS STAFF CONTACT ...Go Back

Prof Dame Lesley Fallowfield

Lesley Fallowfield trained at Guy's Hospital London as a nurse before completing a degree in Experimental Psychology. Research for her DPhil in Psychophysics was done at the Universities of Sussex and Cambridge. Her primary research interests include:

Professor Fallowfield has contributed numerous articles to medical journals and has written three textbooks on QoL and communication in health care.

  • TARGET2

    New series of workshops due to begin September 2024

  • TRUSTING AZ Workshops 2025

    A series of workshops around the UK building on the previous workshops but incorporating new materials covering extra topics and scenarios.

  • BRCA Direct 2

    Following on from the successful BRCA DIRECT trial, NHS England has provided funding to implement the BRCA DIRECT digital pathway in 10-20 centres in England over an 18 month period.

  • LORIS

    A phase III trial of surgery versus active monitoring for Low Risk DCIS (LORIS), incorporating a two year feasibility study. The aim of the main trial is to determine whether women with newly diagnosed low risk DCIS can safely avoid surgery, without detriment to their psychological well-being and can those patients who do require surgery be identified by pathological and radiological criteria.

  • POSNOC

    A randomised controlled trial of axillary treatment in women with early stage breast cancer who have metastases in one or two sentinel nodes. The aim of this trial is to determine whether axillary clearance or radiotherapy can be safely avoided in women receiving chemotherapy and/or hormone therapy following surgery for early stage breast cancer. The trial also explores how aspects of QoL and psychological well-being are affected by fear of cancer recurrence and long term side effects of axillary treatment.

  • TARGET2

    A new series of TARGET workshops commisioned by Exact Sciences.

  • TRUSTING AZ Workshops 2025 Evaluation

    Evaluation of a series of workshops around the UK building on the previous workshops and incorporating new materials covering extra topics and scenarios.

  • HearSay

    Development and implementation of training program from Healthcare Professional on how best to communicate with paitents who have metastatic disease.

  • CANCODE

    In order to develop an educational programme to help communication professionals working with d/Deaf and deaf-blind people (e.g. sign language interpreters) better understand what they may be required to interpret in cancer consultations, we are conducting a survey to find out what communication professionals feel are the biggest challenges when working in cancer consultations.

  • Torr B, Kavanaugh G, Hamill M, Jones C, Harder H, Allen S, ..., Turnbull C.(2025) Uptake, utility and resource requirements of a genetic counselling telephone helpline within the BRCA-DIRECT digital pathway for mainstreamed BRCA testing in patients with breast cancer. Journal of Medical Genetics. (2025;0): 1-9. Find it online here 12/03/2025
  • Wheelwright S, Minton O, Absolom K, Fairvre-Finn C, Fallowfield L, Gilbert ...Shilling V. (2025) Integrating ePROMs: A Key Opportunity for England's National Cancer Plan. Journal of Cancer Policy (44): 100575 Find it online here 10/03/2025
  • Shilling, V., Starkings, R. & Fallowfield, L. Feasibility and acceptability of a virtual learning module for navigating angry conversations in clinical encounters. BMC Med Educ 25, 167 (2025). https://doi.org/10.1186/s12909-025-06726-6 Find it online here 01/02/2025
  • Bedia J, Jacobs I, Ryan A, Gentry-Maharaj A, Burnell M, Singh N ... Skates S. (2025) Estimating the ovarian cancer CA-125 preclinical detectable phase, in-vivo tumout doubling time, and window for detection in early stage: an exploratory analysis of UKCTOCS. eBioMedicine, 112: 105554 Find it online here 14/01/2025
  • Torr B, Jones C, Kavanaugh G, Hamill M, Allen S, Choi S et al. (2024)BRCA-DIRECT digital pathway for diagnostic germline genetic testing within a UK breast oncology setting: a randomised, non-inferiority trial. British Journal of Cancer 131, 1506-1515. Find it online here 01/10/2024
  • Sharon F. McGee, Mark Clemons, Gregory Pond, Jean-Michel Caudrelier, Michelle Liu, Mashari Jemaan Alzahrani, ... Jean-Marc Bourque (2024) A Randomized Trial Comparing Concurrent versus Sequential Radiation and Endocrine Therapy in Early-Stage, Hormone-Responsive Breast Cancer. Current Oncology; 31 (8) 4531-4545 Find it online here 07/08/2024
  • Jenkins V, Habibi R, Hall V, Leonard P, Lawn A, Naik J,...Fallowfield L. (2024) Roll-out of an educational workshop to improve knowledge and self-confidence of healthcare professionals engaged in mainstreaming of breast cancer genetics. PLoS ONE 19(7): e0307301. Find it online here 19/07/2024
  • Fatima Cardoso, Shani Paluch-Shimon, Eva Schumacher-Wulf, Leonor Matos, Karen Gelmon, Matti S. Aapro, ... Eric P. Winer (2024). 6th and 7th International consensus guidelines for the management of advanced breast cancer (ABC guidelines 6 and 7). The Breast; 76: 1-66 Find it online here 18/06/2024
  • Treasure T, Macbeth F, Fallowfield L. (2024) A prospective multicentre cohort study of colorectal lung metastasectomy with a nested randomized controlled trial: the key points from the pulmonary metastasectomy in colorectal cancer study. European Journal of Cardiothoracic Surgery; 65 (6): ezae216. Find it online here 03/06/2024
  • Burstein H, DeMichele A, Fallowfield L, Somerfield M, & Henry NL. (2024). Endocrine and Targeted Therapy for Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2 - Negative Metastatic Breast Cancer - Capivasertib-Fulvestrant: ASCO Rapid Recommendation Update. Journal of Clinical Oncology; Volume 42: 1450-1455 Find it online here 02/04/2024
lesley
EMAIL: adminshore-c@sussex.ac.uk PHONE: 01273 873019 BlueSky: https://bsky.app/profile/shore-c.bsky.social LOCATION: MAP